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Objective: To investigate the relationship between established acute inflammatory markers in COVID-19 patients 
with Mean platelet volume (MPV) and Platelet large cell ratio (P-LCR). 
 
Materials and Methods: This was a retrospective longitudinal study conducted at Fauji Foundation Hospital, 
Rawalpindi from 10th June to 10th August 2020. Biochemical parameters i.e. CRP, serum ferritin, LDH, and pro-
BNP as well as hematological parameters (MPV and P-LCR) were noted once every week during admission of all 
the COVID-19 positive patients. 
Data were analyzed using IBM-SPSS version 23. Repeated measure ANOVA using a generalized linear model 
was done to check the trend of values during the duration of their stay. Pearson Correlation analysis and 
regression models were estimated to check the relationship of MPV and P-LCR with C- reactive protein, serum 
Ferritin, LDH, and pro-BNP. P-values less than 0.05 were considered statistically significant. 
 
Results: The mean age of the studied group was 55.47 (SD=±15.0) years with the female to male ratio being 2:1. 
Mean platelet volume showed a statistically significant positive correlation with the established set of 
inflammatory markers other than pro-BNP with a p-value of less than 0.05.P-LCR however showed a positive 
correlation with CRP (p-value of less than 0.05) only with no significant correlation with other biochemical 
markers. 
 
Conclusion: MPV is reported on routine complete blood count report (CBC). It is readily available at even the 
most under-resourced health centers; therefore reporting the platelet indices does not require extra testing, 
sampling, or reagent cost. A statistically significant positive correlation amongst the established acute 
inflammatory markers and relatively understudied platelet indices (MPV) in COVID-19 provides a cost-effective, 
readily available, and time-efficient tool for marking disease progression.  
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Introduction 
 
Beginning in Wuhan, China in December 2019, 
COVID-19  had quickly become a pandemic with a 
huge global impact.1,2 According to the report of the 
World Health Organization (WHO), published on 6th 
July 2020, 11,327,790 COVID-19 cases were confirmed 
worldwide, with 532,340 deaths.2 In Pakistan, the first 
case of COVID-19 was reported from Karachi on 
February 26, 2020. The virus has been swiftly 
spreading all across the country since then leading to 
increase mortality and morbidity. Pakistan has most 
likely contracted cases through travel, by land, and air 
with neighboring countries.3 COVID-19 has a varied 
presentation, from asymptomatic carriers to 
symptomatic patients having fever, breathing 
difficulties, and pneumonia-like condition. More 
severe conditions with respiratory failure requiring 
mechanical ventilation, multi-organ failure, and DIC 
have also been observed.4 
The diagnosis of COVID-19 is primarily done through 
RNA detection by PCR whereas serological 
surveillance is done through antibody testing. The role 
of diagnostics lab tests has extended far beyond 
disease detection. Many laboratory parameters are 
consistently being used for monitoring the disease and 
its severity.5 
In COVID-19, symptomatic patients are monitored 
through various biochemical markers including LDH, 
CRP, Ferritin, interleukin-6, D-dimer, etc. at various 
stages of the disease process. The rising parameters 
indicate poor prognosis and worsening of the disease. 
These parameters along with the clinical behavior of 
the patient are the pertinent guide for the physician for 
further management.6,7,8 Other than biochemical 
markers, many hematological parameters exhibited on 
Complete blood count are considered helpful in 
understanding the disease process and its progression. 
Amongst these, lymphocyte count, platelet 
lymphocyte ratio, and neutrophil-lymphocyte ratio 
have been extensively studied.7 Platelet indices such as 
mean platelet volume (MPV) and platelet large cell 
ratio (P-LCR) are routinely used in clinical practice 
worldwide as the index of inflammation.8 Higher MPV 
 and P-LCR have been found in sepsis to be a poor 
prognostic factor.9 In COVID-19 the role of these 
platelet indices has been under-investigated. There is a 
paucity of data that has assessed mean platelet volume 
and other platelet parameters in COVID-19. 
Furthermore, there is only scarce data documenting 
MPV and P-LCR  to have an association with 
mortality, morbidity, or disease progression.10 No 
correlation amongst the established biochemical 
markers like CRP, LDH, Ferritin, and platelet indices 
have been established. 
In this study, we aimed to investigate the relationship 
between established acute inflammatory markers in 
COVID-19 and MPV, and P-LCR.  Platelet and its 
indices are readily available, cost-effective, and time-
efficient parameters for continuous monitoring even in 
the most under-resourced centers. The study of any 
correlation between routine monitoring markers, 
platelet indices, and disease process will help to devise 
a cost-efficient monitoring plan for COVID-19 affected 
patients globally especially in underdeveloped 
countries.  
  
Materials and Methods 
 
It is a retrospective study carried out at Fauji 
Foundation Hospital Rawalpindi. After informed 
consent from patients for using their data, the data 
was noted for all the patients admitted in Fauji 
Foundation Hospital, Rawalpindi with positive PCR 
for COVID-19 from 10th June till 10th August  2020.  
Amongst these, the patients with short hospital stays 
(less than one week) were not included in the study to 
avoid errors or bias in the data analysis. The data of all 
the patients with significant medical stays (more than 
one week) was recorded. Categorical variables like age 
and gender were noted. Biochemical parameters like 
CRP, serum ferritin, LDH, and pro-BNP as well as 
hematological parameters (MPV and P-LCR) were 
noted on the day of admission and once every week 
during their admission. Serum ferritin and pro-BNP 
were performed on Siemen’s ADVIA CENTAUR XP. 
The assay is a fully automated two-site sandwich 
immunoassay using direct chemiluminescent 
technology. Serum LDH was performed on Beckmen 
coulter DxC 700AU by enzymatic method IFCC 
(international federation for clinical chemistry). CRP 
qualitative was performed by Latex agglutination slide 
test on Huma Tex CRP kits. MPV and P-LCR were 
reported on the routine CBC performed on Sysmex 
XN-1000 series. 
Statistical Analysis: Data were stored and analyzed 
using IBM-SPSS version 23.0, Mean with standard 
deviation were reported for platelet indices and other 
studied parameters, Repeated measure ANOVA using 
the generalized linear model was done to check the 
trend of values during the duration of their stay. 
Pearson Correlation analysis was done to check the 
relationship of MPV and platelet large cell ratio with 
C-reactive protein, serum Ferritin, LDH, and pro-BNP. 
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Further regression models were estimated to measure 
the effect of studied parameters on platelet indices 
after adjusting with age and gender. P-values less than 
0.05 were considered statistically significant. A pie 
chart was used to show the distribution of gender and 
scatter plots were also used to represent the trend of 




In the present study, fifty-five patients were admitted 
to Fauji Foundation Hospital, Rawalpindi from 10th 
June to 10th August  2020 with a positive PCR for 
COVID-19. Of these, forty patients had a hospital stay 
of more than one week. Fifteen patients were either 
discharged early in their stay or left against medical 
advice. The data of the forty patients with a hospital 
stay of more than one week was recorded, analyzed, 
and reported weekly. 
The mean age of the studied group was 55.47 
(SD=±15.0) years.  There was a female preponderance 
with a percentage of 67.5% (n=27) whereas male 
patients were 32.5% ( n=13). Results showed the mean 
serum Ferritin levels at week–I were 625.7 ng/ml 
(SD=±653.8), at week-II 802.6ng/ml (SD=±802.6) and 
week-III 945.3 ng/ml (SD=±784.5) increasing 
significantly with p<0.05. (Table 1) 
The correlation analysis of platelet indices with the 
established set of inflammatory markers other than 
pro-BNP done at each week of hospital stay showed 
statistical significance with a p-value of less than 0.05. 
The correlation analysis of MPV and P-LCR with Pro-
BNP was statistically insignificant. (Table 2) 
The outcome of regression analysis to study the effect 
on MPV of studied parameters among COVID patients 
showed that at week-I one unit increase in serum 
Ferritin causes 0.1 times to increase in MPV with a p-
value of 0.04. At week –II among patients with positive 
C-reactive protein MPV increased 2.1 times on average 
(p<0.01), and one unit increase in LDH gives a 0.1 unit 
increase in MPV on average (p<0.01).  Models were 
adjusted for age and gender. (Table 3). 
Similarly, the effect on P-LCR of established 
parameters in COVID-19 patients showed that only at 
week-II CRP gives a positive association with an 
increase in platelet large cell ratio, (p<0.01), all other 
parameters also give positive effect except pro-BNP 
but found statistically insignificant. The models were 
adjusted for age and gender. (Table 4) 
Table 1: Platelet Indices and other studied parameters of COVID Samples 
Parameters Week-I Week-II Week-III P-value 
Serum Ferritin   (ng/ml) 625.7 802.6 945.3 0.01* 
LDH (U/L) 512.5 623.3 714.1 0.18 
Pro-BNP (pg./ml) 3794.6 4486.9 4760.8 0.06 
Mean Platelet Volume 11.5 12.0 12.7 0.06 
Platelet Large Cell Ratio 32.3 34.5 37.4 0.17 
C-reactive Protein a 0.90 0.77 0.90 0.33 
*p<0.05 was considered significant using Repeated Measure ANOVA 
a: Mean proportion of positive cases was reported 
 



























r-value 0.389 0.378 0.648 0.653 0.298 0.416 
p-value 0.01* 0.01* <0.01* <0.01* 0.202 0.068 
Serum Ferritin 
 
r-value 0.523 0.374 0.604 0.542 0.503 0.362 
p-value <0.01* 0.01* <0.01* <0.01* 0.02* 0.117 
LDH 
 
r-value 0.410 0.284 0.631 0.502 0.564 0.464 
p-value <0.01* 0.076 <0.01* <0.01* 0.01* 0.03* 
Pro-BNP r-value 0.252 0.220 0.334 0.381 0.316 0.249 
p-value 0.116 0.173 0.03* 0.01* 0.175 0.289 
*p<0.05 was considered statistically significant for Pearson correlation 
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Table 3: Effect of Studied Parameters on MPV in COVID patients 
Parameters MPV week-I MPV week-II MPV week-III 
β± S.E p-value β± S.E p-value β± S.E p-value 
c-reactive protein (1.2±0.9) 0.16 (2.1±0.6) <0.01* (0.2±1.5) 0.92 
Serum Ferritin (0.1±0.1) 0.04* (0.1±0.1) 0.07 (0.1±0.1) 0.55 
LDH (0.1±0.1) 0.15 (0.1±0.1) <0.01* (0.1±0.1) 0.14 
Pro-BNP (-0.1±0.1) 0.46 (-0.1±0.1) 0.11 (-0.1±0.1) 0.88 
Adjusted R-square 0.30 0.63 0.26 
*p<0.05 was considered significant for Beta Coefficient 
Dependent Variables: Week-I MPV, Week-II MPV, Week-III MPV 
Independent variables C-reactive protein, serum Ferritin, LDH, Pro-BNP at respective weeks 
Model(s) were adjusted for age and gender 
 
Table 4: Effect of Studied Parameters on Platelet Large Cell ratio in COVID patient 
Parameters 
 
Platelet Large Cell Ratio 
week-I 
Platelet Large Cell Ratio 
week-II 
Platelet Large Cell Ratio 
week-III 
β± S.E p-value β± S.E p-value β± S.E p-value 
c-reactive protein (9.4±5.1) 0.07 (12.7±3.3) <0.01* (13.9±8.8) 0.13 
Serum Ferritin (0.1±0.1) 0.32 (0.1±0.1) 0.35 (0.1±0.1) 0.93 
LDH (0.1±0.1) 0.41 (0.1±0.1) 0.11 (0.1±0.1) 0.1 
Pro-BNP (-0.1±0.1) 0.88 (-0.1±0.1) 0.78 (-0.1±0.1) 0.64 
Adjusted R-square 0.27 0.48 0.12 
*p<0.05 was considered significant for Beta Coefficient 
Dependent Variables: Platelet Large cell at week-I, week-II, and Week-III respectively 
Independent variables C-reactive protein, serum Ferritin, LDH, Pro-BNP at respective weeks 




The present study was conducted to evaluate any 
correlation that exists between the relatively 
understudied platelet indices (MPV and P-LCR) and 
established prognostic biomarkers in COVID-19 
patients. A statistically significant positive correlation 
will enable the clinicians to use the fairly cost-effective 
platelet indices provided in routine CBC to monitor 
disease progression in COVID-19 instead. This will not 
only be cost-effective but readily available at even the 
most under-resourced centers. 
The study exhibited a statistically significant 
correlation (p-value<0.05) between MPV with the 
already established inflammatory markers i.e. serum 
ferritin, CRP, and LDH in patients with COVID-19. P-
LCR showed a statistically significant (p-value<0.05) 
correlation with CRP only. A correlation of these 
platelet indices with pro-BNP was not found to be 
statistically significant.  
Activated platelets tend to release many substances 
that play a role in inflammation.11 This Platelet 
hyperactivity also occurs in COVID-19. Mean platelet 
volume (MPV) is considered a proxy marker of this 
platelet activation. It is a depiction of platelet size. It 
ranges from 7.5 fL to 10.5fL.12 An increase in MPV is 
correlated with thrombosis and inflammatory 
conditions. Therefore MPV has always been 
considered a useful prognostic indicator for critical 
patients.13,14,15 
Platelet larger cell ratio (P-LCR) is another marker of 
platelet activity. It gives a percentage of all platelets 
with a volume measuring over 12 fL circulating in the 
bloodstream. It normally ranges between 15-35%.14 P-
LCR seems to be more susceptible to alterations in 
platelet size in comparison to MPV, despite their 
correlation.15 
Our study depicted a female preponderance with 27 of 
40 patients being females. In a study conducted locally 
in Pakistan, the gender division in patients with 
COVID-19 showed a male predominance of 89.7%.16 
Similarly a study conducted in China had 31 of 40 
infected patients of the male gender.17 This is in 
contrast to our study. The possible reason for the high 
female proportion in our study is most likely due to 
the fact that Fauji Foundation Hospital, Rawalpindi is 
a welfare hospital catering to the families of veteran 
armed personnel. The main bulk of patients being 
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catered here as out-patient as well in-patient are 
females. 
To the best of our knowledge, there is no such study 
that has correlated mean platelet volume and platelet 
large cell ratio with established acute inflammatory 
markers in COVID-19 specifically. 
Globally few such studies have been conducted that 
have depicted the significance of mean platelet volume 
in COVID-19 patients. Zhang et al.18 in their study 
showed that mean platelet volume is raised in the 
COVID-19 patients as compared to non-COVID-19. 
Furthermore, it tends to increase with the increasing 
severity of the disease. This is fairly comparable to our 
study since in our study, with the increasing trend of 
established biomarkers depicting the severity of the 
disease, mean platelet volume also tended to rise. 
Correlation with the acute inflammatory markers 
however was not done in the aforementioned study.  
Numerous studies have however studied MPV as a 
biomarker in various systemic conditions.12,19,20 Since 
the pathophysiological aspect of some disease for 
example inflammation or tendency to develop a 
thrombotic complication is similar, therefore it could 
also be related to the disease progression in COVID-
19.  
MPV has been labeled and used as an inflammatory 
index in many conditions of systemic inflammation as 
well as diabetes, coronary heart disease, tumors, and 
connective tissue disorders. Ozder A21 in his study 
advocates MPV as an infection indicator in COVID-19 
patients with diabetes as a comorbid. In his study, he 
established raised MPV in patients with diabetes that 
have contracted COVID-19. The present study 
included all patients irrespective of co-morbid. A 
progression in biochemical markers correlated with 
the changes in platelet indices irrespective of the 
presence of co-morbid. 
In another study conducted in China, platelet and its 
parameters are studied in patients with COVID-19.22 
Correlation of Platelet parameters with established 
inflammatory markers however were not studied. In 
the current study, platelet indices were correlated with 
established biomarkers. 
In this study, P-LCR is positively correlated to CRP 
only whereas no statistically significant relationship is 
observed with other biochemical parameters. Since 
there is a scarcity of available data that has studies P-
LCR in COVID-19, therefore, the results cannot be 
compared. In a study conducted by Mertoglu C23 
many hematological and biochemical markers were 
studied in COVID-19 and analysis was made between 
ICU and non-ICU patients. According to this study 
platelet large cell ratio increases in COVID-19 and it 
positively correlates with the severity of the disease. A 
correlation amongst the various parameters however 
was not made. 
To the best of our knowledge, this study is unique 
since it has attempted to trace a correlation between 
CRP, LDH, and serum Ferritin with MPV and P-LCR. 
Amongst the platelet indices, MPV can be used as a 
monitoring marker for COVID-19. Since MPV is a part 
of CBC, utilizing it as a monitoring tool will assist in 
cutting down the load on laboratories as CBC is 




Mean platelet volume shows a statistically significant 
relationship with established acute inflammatory 
markers in COVID-19 whereas platelet large cell ratio 
correlates positively with CRP only. Since CBC 
analyzer is readily available at even the most under-
resourced health centers; therefore reporting the 
platelet indices does not require extra testing, 
sampling, or reagent cost. A statistically significant 
positive correlation amongst the established acute 
inflammatory markers and relatively understudied 
platelet indices (MPV) in COVID-19 provides a cost-
effective, readily available, and time-efficient tool for 
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